CAMBRIDGE, Mass., Mar 10, 2009 (BUSINESS WIRE) -- Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live by Cowen and Company on Tuesday, March 17, 2009 at 10:15 a.m. EDT. The presentation will be webcast from The Marriot Copley Place in Boston and may be accessed under the investor relations tab at www.alkermes.com. The presentation will be archived for 14 days.
Alkermes, Inc. is a fully integrated biotechnology company committed to developing innovative medicines to improve patients' lives. Alkermes developed, manufactures and commercializes VIVITROL(R) for alcohol dependence and manufactures RISPERDAL(R) CONSTA(R) for schizophrenia. Alkermes' robust pipeline includes extended-release injectable, pulmonary and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Headquartered in Cambridge, Massachusetts, Alkermes has research facilities in Massachusetts and a commercial manufacturing facility in Ohio.
SOURCE: Alkermes, Inc.
Alkermes, Inc.
Eva Stroynowski, 617-583-6823
Corporate Communications